Neurogene Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-09-30
|
-0.03
|
-0.41
|
-0.38
|
-1259.00%
|
|
2023-06-30
|
-0.04
|
-0.04
|
0.00
|
0.00%
|
|
2023-03-31
|
-0.22
|
-0.26
|
-0.04
|
-18.18%
|
|
2022-12-31
|
-0.19
|
-0.24
|
-0.05
|
-26.32%
|
|
2022-09-30
|
-0.30
|
-0.24
|
0.06
|
21.13%
|
|
2022-06-30
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2022-03-31
|
-0.30
|
-0.28
|
0.02
|
6.04%
|
|
2021-12-31
|
-0.30
|
-0.28
|
0.02
|
5.31%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-0.41
|
|
2023-06-30
|
-0.78
|
|
2022-06-30
|
-1.12
|
|
2021-06-30
|
-0.80
|
|
2020-06-30
|
-2.87
|
|
2019-06-30
|
-1.03
|
|
2018-06-30
|
-1.69
|
|
2017-06-30
|
-1.89
|
|
2016-06-30
|
-1.91
|
|
2015-06-30
|
-2.25
|
|
2014-06-30
|
-1.79
|